Dr. David Galetto, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1450 E Chestnut Ave, Bldg 3 Suite A, Vineland, NJ 08361 Phone: 856-794-8700 Fax: 856-794-2752 |
News Archive
Obesity appears to be a problem worldwide affecting millions of people in many developed countries.
BioInvent International AB and ThromboGenics NV announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
A new study from Mount Sinai School of Medicine finds that deep brain stimulation (DBS) is a safe and effective treatment for patients with primary generalized dystonia (PGD).
› Verified 7 days ago